University of California San Francisco
Give to UCSFA UCSF-led research team has identified the likely genetic mechanism that causes some patients with multiple sclerosis to quickly progress to a debilitating stage of the disease while other patients progress much more slowly.
Gene mutations that lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism and bipolar disorder, according to new research by UCSF scientists.
UCSF convened 170 of the world’s foremost thinkers, creators and innovators last month at the OME Precision Medicine Summit to identify new approaches and spur action to make medicine more predictive, preventive and precise.
Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
The scientific community at UCSF is reacting positively to the Supreme Court’s unanimous ruling that human genes cannot be patented.
The world's foremost thinkers, creators and innovators convened at the OME Summit at UC San Francisco in May 2013 to make precision medicine a reality. Hailing from diverse backgrounds – from
UCSF has joined nearly 70 other health care, research and patient advocacy organizations in a global alliance to enable researchers and physicians around the world to share genomic and clinical data.
Investigators at Duke Medicine and UCSF have been selected to oversee a nationwide research program on antibacterial resistance, which will focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.
Pharmacologist Lisa Bero, PhD, answers our questions about industry bias in clincial trials.
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Two UCSF scientists — brain researcher Michael Brainard, PhD, and cell biologist Dyche Mullins, PhD — have been selected to be Howard Hughes Medical Institute investigators.